MaRS and J&J to support early-stage technologies

Guest Contributor
September 1, 2010

MaRS Innovation has teamed with Johnson & Johnson Corporate Office of Science and Technology to launch a co-managed and co-financed fund for early-stage development of Toronto-based life sciences technologies. Each party will commit a defined capital pool to support high-potential projects identified by a joint management committee. The objective is to take a technology to preliminary proof-of-concept within 12-24 months and leverage other resources as it moves towards commercialization through licensing or company creation….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.